2386 Results
Solving chronic and recurrent inflammation: Beyond corticosteroid therapy
For most autoimmune diseases, 20-50% of patients relapse within 1-5 years severely increasing healthcare costs and reducing the quality of life of those affected.Funding proposalsSprayable GLMO Mucoadhesive Gel for oral mucositis
Oral mucositis, painful mouth ulcers caused by cancer treatment, can make eating, speaking, and continuing therapy extremely difficult. Current treatments often provide only short-term relief or are uncomfortable to use.Funding proposalsRewiring risk: Catching pain in the act with early preventive neuromodulation
Many people in Aotearoa New Zealand develop chronic pain that becomes long-lasting and difficult to treat, yet research suggests it may be possible to intervene before pain becomes chronic.Funding proposalsREST-Māmā restoring circadian sleep through technology-enhanced midwifery
The weeks after birth are a high-risk time for new mothers. Severe sleep disruption and disturbed body clocks are common and can increase the risk of postpartum anxiety and depression.Funding proposalsPhysics-constrained AI for marker-less tumour localisation in breast surgery
Breast surgery aims to remove the tumour while preserving as much healthy breast tissue as possible.Funding proposalsEconomic policy and people’s health in Aotearoa New Zealand
Economic policy remains one of the most powerful levers governments can pull to shape societal outcomes.Funding proposalsMast cells as drivers and therapeutic targets of endometriosis
Endometriosis is a chronic condition affecting many people in Aotearoa New Zealand, and often leads to years of pain, fatigue, and difficulty with daily life. As a result, the healthcare burden is significant.Funding proposalsDomain-adapted AI for equitable brain-based cognitive assessment in ADHD
ADHD assessment in children currently relies on behavioural tests and parent reports, which cannot easily distinguish whether a child has genuine cognitive limitations or simply performed poorly due to anxiety, fatigue, or cultural discomfort with testing.Funding proposalsImplantable immune memory: A new architecture for precision cancer immunotherapy
Many modern cancer treatments try to help the immune system attack cancer, but they only work if the body already has the right immune cells.Funding proposalsDo antimicrobial peptides work because of what they are, or where they come from
Antimicrobial resistance (AMR) is a growing global health crisis, making once-treatable infections increasingly difficult to cure as antibiotics lose their effectiveness.Funding proposalsDoes the system “fit” women with lobular breast cancer? A national study
Invasive lobular breast cancer (ILC) is common, but it can be difficult to see on standard mammography and may recur later than other breast cancers.Funding proposalsTransforming HIV prevention via an adaptable P-PrEP framework
Aotearoa New Zealand is not on track to meet the government’s goal of eliminating HIV transmission by 2030. HIV pre-exposure prophylaxis (PrEP) plays a critical role in HIV prevention.Funding proposalsDigital epilepsy pathways: How digital and clinical inputs shape care
This research aims to make paediatric epilepsy care fairer and more effective for families in Aotearoa New Zealand. It recognises that treatment resistance in childhood epilepsy arises through two interacting pathways.Funding proposalsEEG-based neuro-subtypes of obesity: towards precision GLP-1 therapy
People with obesity respond very differently to weight-loss medications such as GLP-1 therapies, yet the reasons behind this variation are underexplored.Funding proposalsPreclinical oral health research on a taonga-derived hydrosol
Māori experience higher rates of gum disease and oral inflammation often made worse by barriers to access and treatments.Funding proposalsIntegrating Māori experiences and perspectives in preterm birth research
Preterm birth is a leading cause of infant death and long-term health challenges in New Zealand and whānau Māori experience higher preterm birth rates and poorer outcomes than non-Māori.Funding proposalsTū Wairua: Reducing mild TBI symptoms through Psilocybin-assisted psychotherapy
Psilocybin-assisted psychotherapy (PAT) is an emerging therapeutic option, with preclinical and clinical evidence suggesting benefits in neuroplasticity, emotional processing, and symptom reduction.Funding proposalsA Pilot Study Evaluating Kōwhai-Derived Cytisine for Māori Smoking Cessation
Smoking causes major harm in New Zealand, and Māori are more likely to experience smoking-related illness than non-Māori.Funding proposals